Skip to content
FDA drug shortage status

Is Methylphenidate Hydrochloride Tablet, Extended Release (Concerta) in shortage?

Yes. Methylphenidate Hydrochloride Tablet, Extended Release is on FDA’s drug shortage list (unavailable), last updated Nov 16, 2026.

In shortageFDA status
34packages listed
7unavailable

Why it’s in shortage

  • Demand increase for the drug
  • Discontinuation of the manufacture of the drug
  • Other

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)
    Trigen Laboratories, LLCIn shortageLimited AvailabilityUpdated Nov 16, 2026

    Allocation to current contracted customers

    Maker contact: 800-541-4802

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)
    Trigen Laboratories, LLCIn shortageLimited AvailabilityUpdated Nov 16, 2026

    Allocation to current contracted customers

    Maker contact: 800-541-4802

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10)
    Trigen Laboratories, LLCIn shortageLimited AvailabilityUpdated Nov 16, 2026

    Allocation to current contracted customers

    Maker contact: 800-541-4802

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10)
    Trigen Laboratories, LLCIn shortageLimited AvailabilityUpdated Nov 16, 2026

    Allocation to current contracted customers

    Maker contact: 800-541-4802

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)
    Trigen Laboratories, LLCIn shortageLimited AvailabilityUpdated Nov 16, 2026

    Allocation to current contracted customers

    Maker contact: 800-541-4802

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)
    Trigen Laboratories, LLCIn shortageLimited AvailabilityUpdated Nov 16, 2026

    Allocation to current contracted customers

    Maker contact: 800-541-4802

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30)
    Trigen Laboratories, LLCIn shortageLimited AvailabilityUpdated Nov 16, 2026

    Allocation to current contracted customers

    Maker contact: 800-541-4802

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01)
    Teva Pharmaceuticals USA, Inc.In shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-545-8800

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01)
    Teva Pharmaceuticals USA, Inc.In shortageLimited AvailabilityUpdated Nov 16, 2026

    Estimated recovery: TBD

    Maker contact: 800-545-8800

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01)
    Teva Pharmaceuticals USA, Inc.In shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-545-8800

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01)
    Teva Pharmaceuticals USA, Inc.In shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-545-8800

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37)
    Lannett Company, Inc.In shortageAvailableUpdated Nov 16, 2026

    Maker contact: 844-834-0530

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37)
    Lannett Company, Inc.In shortageUnavailableUpdated Nov 16, 2026

    Estimated recovery: December 2026

    Maker contact: 844-834-0530

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37)
    Lannett Company, Inc.In shortageUnavailableUpdated Nov 16, 2026

    Estimated recovery: December 2026

    Maker contact: 844-834-0530

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37)
    Lannett Company, Inc.In shortageUnavailableUpdated Nov 16, 2026

    Estimated recovery: December 2026

    Maker contact: 844-834-0530

  • Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)
    Vertical Pharmaceuticals, LLCIn shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-541-4802

  • Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)
    Vertical Pharmaceuticals, LLCIn shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-541-4802

  • Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)
    Vertical Pharmaceuticals, LLCIn shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-541-4802

  • Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10)
    Vertical Pharmaceuticals, LLCIn shortageLimited AvailabilityUpdated Nov 16, 2026

    Temporary discontinuation of 100ct

    Maker contact: 800-541-4802

  • Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30)
    Vertical Pharmaceuticals, LLCIn shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-541-4802

  • Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)
    Vertical Pharmaceuticals, LLCIn shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-541-4802

  • Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30)
    Vertical Pharmaceuticals, LLCIn shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-541-4802

  • Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)
    Vertical Pharmaceuticals, LLCIn shortageLimited AvailabilityUpdated Nov 16, 2026

    Temporary discontinuation of 100ct

    Maker contact: 800-541-4802

  • Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30)
    Vertical Pharmaceuticals, LLCIn shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-541-4802

  • Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)
    Vertical Pharmaceuticals, LLCIn shortageLimited AvailabilityUpdated Nov 16, 2026

    Temporary discontinuation of 100ct

    Maker contact: 800-541-4802

  • Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30)
    Vertical Pharmaceuticals, LLCIn shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-541-4802

  • Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)
    Janssen PharmaceuticalsIn shortageAvailableUpdated Nov 3, 2026

    Maker contact: 800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET

  • Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01)
    Janssen PharmaceuticalsIn shortageAvailableUpdated Nov 3, 2026

    Maker contact: 800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET

  • Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01)
    Janssen PharmaceuticalsIn shortageAvailableUpdated Nov 3, 2026

    Maker contact: 800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET

  • Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01)
    Janssen PharmaceuticalsIn shortageAvailableUpdated Nov 3, 2026

    Maker contact: 800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88)
    Sun Pharmaceutical Industries, Inc.In shortageUnavailableUpdated Oct 30, 2026

    Currently not marketed

    Maker contact: 800-818-4555

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88)
    Sun Pharmaceutical Industries, Inc.In shortageUnavailableUpdated Oct 30, 2026

    Currently not marketed

    Maker contact: 800-818-4555

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88)
    Sun Pharmaceutical Industries, Inc.In shortageUnavailableUpdated Oct 30, 2026

    Currently not marketed

    Maker contact: 800-818-4555

  • Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88)
    Sun Pharmaceutical Industries, Inc.In shortageUnavailableUpdated Oct 30, 2026

    Currently not marketed

    Maker contact: 800-818-4555

FDA recalls of Methylphenidate Hydrochloride

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Methylphenidate Hydrochloride Tablet, Extended Release:

Methylphenidate Hydrochloride Tablet, Extended Release shortage questions

Is Methylphenidate Hydrochloride Tablet, Extended Release (Concerta) in shortage?

Yes. Methylphenidate Hydrochloride Tablet, Extended Release is on FDA’s drug shortage list (unavailable), last updated Nov 16, 2026.

Why is there a Methylphenidate Hydrochloride Tablet, Extended Release shortage?

FDA records the reason as: Demand increase for the drug; Discontinuation of the manufacture of the drug; Other.

What should I do if I can’t get Methylphenidate Hydrochloride Tablet, Extended Release?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.